Reassessing COVID-19 Vaccine Safety: A Five-Year Analysis of VAERS Reports on Harms and Mortality – The COVID-19 Long Haul FoundationLINKIE
According to CDC data, out of hundreds of millions of doses administered, the number of scientifically confirmed deaths causally linked to COVID-19 vaccines is in the dozens (largely linked to rare but severe blood clotting issues or severe allergic reactions early in the rollout)
You are correct. Out of hundreds of millions of doses administered across the country, scientific and clinical reviews by the Centers for Disease Control and Prevention (CDC) and the FDA have confirmed only a few dozen deaths causally linked to the vaccines. [1]
The vast majority of these extremely rare causal deaths were associated with early rollout issues and two specific complications: [1]
To put these numbers in perspective, the CDC manages the Vaccine Adverse Event Reporting System (VAERS) to track any health issues that happen after vaccination. Health officials emphasize that a report of death in VAERS does not mean the vaccine caused it; every reported death is rigorously investigated using death certificates, autopsies, and medical records to determine the true cause of death. [1, 2, 3]
- Severe Allergic Reactions (Anaphylaxis): A very small number of fatal anaphylactic reactions occurred early in the rollout, which is why clinical providers mandate a 15-to-30-minute observation period post-injection.
- Rare Blood Clotting Issues (TTS): A condition known as Thrombosis with Thrombocytopenia Syndrome (TTS) was causally linked to the viral vector COVID-19 vaccines (such as the Johnson & Johnson/Janssen shot). This rare complication resulted in a few dozen confirmed fatalities before the vaccine was ultimately pulled from the market as safer, updated alternatives became available. [1, 2, 3, 4, 5]
Signal Detection and Long-Term Harm Indicators
While VAERS is not designed for long-term tracking, several patterns suggest potential areas of concern:
A. Myocarditis and Pericarditis
- Strong signal in males aged 12–24, especially after second mRNA dose
- Some cases required hospitalization and long-term cardiac monitoring
- Peer-reviewed studies confirm elevated risk compared to baseline
- Reports of seizures, Guillain-Barré syndrome, and paresthesia increased over time
- A 2024 international study flagged a possible link between the Moderna vaccine and rare neurological conditions
- Longitudinal follow-up is lacking, but persistent symptoms were noted in many reports
- VAERS includes reports of new-onset autoimmune disorders post-vaccination (e.g., lupus, rheumatoid arthritis)
- Causality is unproven, but temporal clustering and recurrence across manufacturers suggest a need for targeted study
- Thousands of reports cite menstrual irregularities, heavy bleeding, or amenorrhea
- These effects were initially dismissed as anecdotal but have since prompted NIH-funded studies
- VAERS data alone cannot confirm long-term reproductive harm, but the volume of reports is nontrivial